D47.02 - Systemic mastocytosis
- Applicable to Systemic mastocytosis
- The 2025 edition of ICD10-CM D47.02 became effective on October 1, 2024.
- This is the American ICD10-CM version of D47.02 - other international versions of ICD10 D47.02 may differ.
- D47.02 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion Term
- Indolent systemic mastocytosis
- Isolated bone marrow mastocytosis
- Smoldering systemic mastocytosis
- Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
Type 1 Excludes
- aggressive systemic mastocytosis (C96.21)
- mast cell leukemia (C94.3-)
codeAlso
- , if applicable, any associated hematological non-mast cell lineage disease, such as:
- acute myeloid leukemia (C92.6-, C92.A-)
- chronic myelomonocytic leukemia (C93.1-)
- essential thrombocytosis (D47.3)
- hypereosinophilic syndrome (D72.1)
- myelodysplastic syndrome (D46.9)
- myeloproliferative syndrome (D47.1)
- non-Hodgkin lymphoma (C82-C85)
- plasma cell myeloma (C90.0-)
- polycythemia vera (D45)
The following codes above D47.02 contain annotation back-references that may be applicable to D47.02:
Chapter: C00-D49 Neoplasms
Section: D37-D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
Category: D47 Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
Billable/Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com